125 related articles for article (PubMed ID: 7284269)
1. Effect of anthralin on stratum corneum antigenicity and polymorphonuclear leukocyte chemotaxis.
Langner A; Chorzelski TP; Fraczykowska M; Beutner EH; Jablonska S
Br J Dermatol; 1981 Aug; 105 Suppl 20():62-3. PubMed ID: 7284269
[No Abstract] [Full Text] [Related]
2. The enhanced monocyte and neutrophil chemotaxis in psoriasis is normalized after treatment with psoralens plus ultraviolet A and anthralin.
Ternowitz T
J Am Acad Dermatol; 1987 Jun; 16(6):1169-75. PubMed ID: 3597858
[TBL] [Abstract][Full Text] [Related]
3. Detection of anthralin in skin during treatment.
Juhlin L; Schroot B
Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415
[TBL] [Abstract][Full Text] [Related]
4. Anthralin therapy for psoriasis.
Statham BN; Ryatt KS; Rowell NR
J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):303-4. PubMed ID: 6480932
[No Abstract] [Full Text] [Related]
5. Advances in the use of anthralin.
Seville RH
J Am Acad Dermatol; 1981 Sep; 5(3):319-21. PubMed ID: 7263977
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in the mode of action of anthralin in the treatment of psoriasis.
Br J Dermatol; 1981 Aug; 105 Suppl 20():1-114. PubMed ID: 7284252
[No Abstract] [Full Text] [Related]
7. Anthralin therapy for psoriasis. A new look at an old compound.
Gorsulowsky DC; Voorhees JJ; Ellis CN
Arch Dermatol; 1985 Dec; 121(12):1509-11. PubMed ID: 4062331
[No Abstract] [Full Text] [Related]
8. Treatment of psoriasis with the Ingram anthralin paste regimen.
Ross JB; Guptill J
Can Med Assoc J; 1982 Mar; 126(5):496. PubMed ID: 7066806
[No Abstract] [Full Text] [Related]
9. Cytokinetic effects of anthralin on psoriatic keratinocytes.
Pullmann H; Enderer K; Steigleder GK
Br J Dermatol; 1981 Aug; 105 Suppl 20():55-6. PubMed ID: 6169362
[No Abstract] [Full Text] [Related]
10. Anthralin inhibition of intraepidermal pustule formation.
Stone OJ
Int J Dermatol; 1986 Mar; 25(2):136. PubMed ID: 3699956
[No Abstract] [Full Text] [Related]
11. Ultrastructural changes in psoriatic epidermis following anthralin treatment.
Wilborn WH; Montes LF
J Cutan Pathol; 1974; 1(3):132-50. PubMed ID: 4377841
[No Abstract] [Full Text] [Related]
12. Innovative use of anthralin. An overview of past, present and future developments.
Farber EM; Nall L
Br J Dermatol; 1981 Aug; 105 Suppl 20():111-4. PubMed ID: 7284256
[No Abstract] [Full Text] [Related]
13. Treatment of psoriasis vulgaris: gentleness to the entire psoriatic skin and the use of low concentrations of anthralin.
Brody I
Br J Dermatol; 1981 Aug; 105 Suppl 20():109-10. PubMed ID: 7284255
[No Abstract] [Full Text] [Related]
14. [Disappearance of psoriactic lesions under the effect of anthralin].
Chowaniec O
Przegl Dermatol; 1976; 63(5):665-71. PubMed ID: 1005760
[No Abstract] [Full Text] [Related]
15. Anthralin and chrysarobin: a reexamination of the origins and early use.
Steger JW; Hollander A
Arch Dermatol; 1982 Sep; 118(9):625-6. PubMed ID: 7114862
[No Abstract] [Full Text] [Related]
16. [Psoriasis therapy with retinoid].
Marghescu S; Lubach D; Rudolph PO
Z Hautkr; 1982 Oct; 57(19):1410-20. PubMed ID: 6755934
[TBL] [Abstract][Full Text] [Related]
17. A 'novel' action of anthralin.
Lotti T; Brunetti L; Panconesi E
Arch Dermatol; 1986 Jul; 122(7):748-9. PubMed ID: 3729504
[No Abstract] [Full Text] [Related]
18. Anthralin cream as short contact therapy for psoriasis.
Miller AC
Cutis; 1985 Jun; 35(6):578-82. PubMed ID: 4017653
[TBL] [Abstract][Full Text] [Related]
19. [Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar].
Schauder S; Mahrle G
Z Hautkr; 1985 Jun; 60(11):875-83. PubMed ID: 3160177
[TBL] [Abstract][Full Text] [Related]
20. [Modern psoriasis therapy].
Mahrle G
Z Hautkr; 1984 May; 59(10):645-6. PubMed ID: 6741203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
